Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS
Go back to Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS| (NASDAQ: COYA) | Delayed: 5.86 +0.20 (3.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.66 | 52 Week High | $ | |||
| Open | $5.75 | 52 Week Low | $ | |||
| Day High | $6.10 | P/E | N/A | |||
| Day Low | $5.57 | EPS | $ | |||
| Volume | 107,486 | |||||

